Antigenics Revenue and Competitors
Estimated Revenue & Valuation
- Antigenics's estimated annual revenue is currently $4.5M per year.
- Antigenics's estimated revenue per employee is $155,000
Employee Data
- Antigenics has 29 Employees.
- Antigenics grew their employee count by 4% last year.
Antigenics's People
| Name | Title | Email/Phone |
|---|
Antigenics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $4.2M | 27 | -7% | N/A | N/A |
#10 | $10.1M | 65 | 5% | N/A | N/A |
What Is Antigenics?
N/A
Total Funding
29
Number of Employees
$4.5M
Revenue (est)
4%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Antigenics News
2022-04-20 - Therapeutic Vaccines Market Size, Scope And Forecast | Bavarian ...
Bavarian Nordic, Argos Therapeutics, Antigenics, Affiris, Celldex Therapeutics, Biovest International, Cel-Sci, Celtic Pharma,...
2022-04-17 - Agenus: Not Quite Enough
It went public in 2000 under the name Antigenics. Its S-1 described its initial therapeutic candidate Oncophage, at the time undergoing a...
Other Companies in
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $4.6M | 29 | 26% | N/A |
#2 | $5M | 29 | 12% | N/A |
#3 | $7.5M | 29 | 4% | N/A |
#4 | $3.6M | 29 | -22% | $78.5M |
#5 | $5M | 29 | 0% | N/A |